Skip to content
Aperlena

Poland - General systemic anti-infective medicines, vaccines, anticancer and immunomodulating agents - Supply of medicinal products

Original Polska - Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne - Dostawy produktów leczniczych

Open Contract notice

Key facts

Closes in
21 days
Estimated value
€363,511 converted from PLN
Where
Poland Małopolskie
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Original language
Polish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 6 days ago
Notice number
645363-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 34 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 18 different companies have won the last 19 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Expected final price vs the published estimate
-0.2%

Based on 19 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The buyer is procuring the supply of medicinal products, divided into 18 lots. Lot 1 covers non-pegylated liposomal doxorubicin, lot 2 denosumab, lot 3 abiraterone acetate, lot 4 aprepitant, lot 5 zoledronic acid, lot 6 rituximab, lot 7 azacitidine, lot 8 tretinoin, lot 9 trabectedin, lot 10 mesna, lot 11 peginterferon alfa-2a, lot 12 vinorelbine, lot 13 various medicinal products, lot 14 panitumumab, lot 15 denosumab, lot 16 aflibercept, lot 17 bosutinib, and lot 18 paclitaxel in the form of a nanoparticle albumin-bound complex. Additional products named include carfilzomib, blinatumomab, romiplostim, cemiplimab, crizotinib, lorlatinib, durvalumab, olaparib, atezolizumab, alectinib, trastuzumab, pertuzumab, obinutuzumab, ixazomib, niraparib and enzalutamide.

Description

Przedmiot zamówienia obejmuje 18 części: Część nr 1: Doxorubicinum liposomanum nonpegylatum Część nr 2: Denosumabum Część nr 3: Octan abirateronu Część nr 4: Aprepitant Część nr 5: Kwas zoledronowy Część nr 6: Rytuksymab Część nr 7: Azacytydyna Część nr 8: Tretinoinum Część nr 9: Trabectedinum Część nr 10: Mesna Część nr 11: Peginterferon alfa-2a Część nr 12 : Vinorelbinum Część nr 13: Różne produkty lecznicze Część nr 14: Panitumumab Część nr 15 : Denosumab Część nr 16 : Aflibercept Część nr 17:Bosutynib Część nr 18: Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą Karfilzomib; Blinatumomab; Romiplostym; Cemiplimabum; Triflurydyna + Typiracyl; Kryzotynib; Lorlatynib; Inotuzumab ozogamycyny; Gemtuzumab ozogamycyny; Ozymertynib; Durwalumab; Olaparyb; Acalabrutinibum; Atezolizumab; Alektynib; Entrectinibum; Trastuzumab; Pertuzumab; Trastuzumabum + Pertuzumabum; Trastuzumab emtanzyna; Polatuzumab wedotyny; Obinutuzumab; Brygatynib; Iksazomib; Brentuksymab wedotyny; Niraparyb; Enzalutamid; Lonkastuksymabu tezyryna; Betaina bezwodna

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Polish.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago

More from this buyer

Full buyer profile

4 open tenders right now

Who usually wins this buyer's contracts in this sector

Based on 19 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 35 comparable contracts this buyer awarded in this sector over the last 4 years.

Lower quartile
€205,237
Median award
€619,851
Upper quartile
€1.2M

This tender is estimated 41.4% below that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,443,725
10,086 open across Europe right now 97% below sector average
Buyer track record on Aperlena
81 notices tracked · 56 awarded
€922,915,226 in awarded contracts

Never miss a tender like this

910 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

21 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language